High throughput screen for the improvement of inducible promoters for tumor microenvironment cues
Authors:
Open Access
- 3 May 2022
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-12
Abstract
Cancer immunotherapies are highly potent and are gaining wide clinical usage. However, severe side effects require focusing effector immune cell activities on the tumor microenvironment (TME). We recently developed a chimeric antigen receptor tumor-induced vector (CARTIV), a synthetic promoter activated by TME factors. To improve CARTIV functions including background, activation levels, and synergism, we screened a library of promoters with variations in key positions. Here, we present a screening method involving turning ON/OFF stimulating TNFα and IFNγ cytokines, followed by sequential cell sorting. Sequencing of enriched promoters identified seventeen candidates, which were cloned and whose activities were then validated, leading to the identification of two CARTIVs with lower background and higher induction. We further combined a third hypoxia element with the two-factor CARTIV, demonstrating additional modular improvement. Our study presents a method of fine-tuning synthetic promoters for desired immunotherapy needs.Keywords
This publication has 46 references indexed in Scilit:
- Design, construction and characterisation of a synthetic promoter library for fine-tuned gene expression in actinomycetesMetabolic Engineering, 2013
- Patient monitoring and follow‐up in lentiviral clinical trialsThe Journal of Gene Medicine, 2013
- A Comprehensive Profile of ChIP-Seq-Based STAT1 Target Genes Suggests the Complexity of STAT1-Mediated Gene Regulatory MechanismsGene Regulation and Systems Biology, 2013
- Extensive characterization of NF-κB binding uncovers non-canonical motifs and advances the interpretation of genetic functional traitsGenome Biology, 2011
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2Molecular Therapy, 2010
- Synthetic design of strong promotersProceedings of the National Academy of Sciences, 2010
- The tumor microenvironment and its role in promoting tumor growthOncogene, 2008
- Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoterGene Therapy, 2004
- Regulation of DNA binding by Rel/NF-κB transcription factors: structural viewsOncogene, 1999
- A Novel Tumor-Specific Replication-Restricted Adenoviral Vector for Gene Therapy of Hepatocellular CarcinomaHuman Gene Therapy, 1999